No way! But... [Design Issues]

posted by ElMaestro  – Denmark, 2019-12-06 14:14 (1794 d 15:21 ago) – Posting: # 20941
Views: 8,691

Hello, both,

❝ ❝ At this situation, should this subject's data with one period be included in the BE assessment?


❝ No, you could not.


We do not need a T-R comparison in each subject to do an analysis. We are just stuck in that paradigm. We could in principle fit a model with missing period data. And all data could be used for the calculation of the CI.
I do not know why there is a regulatory tradition for only using completers - I would say there is even a potential scientific and ethical advantage of using all period data.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,280 posts in 4,889 threads, 1,655 registered users;
54 visitors (0 registered, 54 guests [including 12 identified bots]).
Forum time: 05:35 CET (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5